60 acast.com IPM’s insider coverage of the AMP meeting https://shows.acast.com/ipms-insider-coverage-of-the-amp-meeting en Kathryn Ryan INSIDE PRECISION MEDICINE,AMP 2024 Kathryn Ryan Inside Precision Medicine, reports on the 2024 edition of the Association for Molecular Pathology (AMP) annual meeting in Vancouver, Canada.

Hosted on Acast. See acast.com/privacy for more information.

]]> Inside Precision Medicine, reports on the 2024 edition of the Association for Molecular Pathology (AMP) annual meeting in Vancouver, Canada.

Hosted on Acast. See acast.com/privacy for more information.

]]> false Kathryn Ryan info+6740af46ec59709ba5114ba5@mg-eu.acast.com 6740af46ec59709ba5114ba5 ipms-insider-coverage-of-the-amp-meeting episodic https://assets.pippa.io/shows/6740af46ec59709ba5114ba5/1732294074302-6d44870b-3643-4fd3-b345-f31377db53b0.jpeg https://shows.acast.com/ipms-insider-coverage-of-the-amp-meeting IPM’s insider coverage of the AMP meeting AMP 2024: Trends and Insights from Vancouver AMP 2024: Trends and Insights from Vancouver Fri, 22 Nov 2024 16:25:55 GMT 18:52 6740b09366b40d0b00700713 false https://shows.acast.com/ipms-insider-coverage-of-the-amp-meeting/episodes/amp-2024-trends-and-insights-from-vancouver 6740b09366b40d0b00700713 6740af46ec59709ba5114ba5 amp-2024-trends-and-insights-from-vancouver full Inside Precision Medicine’s VP and publisher Bill Levine joins North American Editor Jonathan D. Grinstein, PhD, for a recap of how the molecular pathology community—from clinical labs and health systems to the biopharma industry—is reacting to the FDA’s ruling on laboratory-developed tests (LDTs), integrating advancements in digital pathology and precision medicine into clinical care, and more.


Produced by Bill Levine

Hosted by Jonathan D. Grinstein

Music provided by Oleksii Holubiev

Audio mixed and mastered by Jason Mack


Hosted on Acast. See acast.com/privacy for more information.

]]> Inside Precision Medicine’s VP and publisher Bill Levine joins North American Editor Jonathan D. Grinstein, PhD, for a recap of how the molecular pathology community—from clinical labs and health systems to the biopharma industry—is reacting to the FDA’s ruling on laboratory-developed tests (LDTs), integrating advancements in digital pathology and precision medicine into clinical care, and more.


Produced by Bill Levine

Hosted by Jonathan D. Grinstein

Music provided by Oleksii Holubiev

Audio mixed and mastered by Jason Mack


Hosted on Acast. See acast.com/privacy for more information.

]]>